Article

Xerostomia after radiotherapy and its effect on quality of life in head and neck cancer patients.

Kerman Neuroscience Research Center, Kerman, Iran.
Archives of Iranian medicine (Impact Factor: 1.11). 04/2012; 15(4):214-8.
Source: PubMed

ABSTRACT Xerostomia is one of the one complications following radiotherapy that can affect quality of life (QoL). This study aims to assess the severity of xerostomia in patients with head and neck cancers after radiotherapy and its effect on QoL.
In this longitudinal prospective study, the severity of xerostomia and related QoL were was assessed in 63 head and neck cancer patients who referred to the Radiotherapy Ward. Patients completed a xerostomia questionnaire (XQ) at the beginning, and 2, 4, and 6 weeks after treatment over a period of 6 months. Additionally, unstimulated saliva was collected using the spitting method at all 4 visits.
QoL significantly worsened with increased time (P = 0.0001); meanwhile, the severity of xerostomia increased significantly (P = 0.0001). However, there was no significant change in the amount of saliva at these 4 time points (P = 0.23). Regression analysis showed that with each milliliter decrease in saliva secretion, the QoL score decreased 2.25%. With one score increase in xerostomia, from the QoL mean score there was a 1.65% decrease.
The decrease in saliva and xerostomia that resulted from radiotherapy plays an important role in worsening QoL among patients who undergo radiotherapy for head and neck cancers. Although the amount of saliva has a significant association with QoL, the xerostomia score which shows subjects' general feeling also independently impacts QoL. In future studies, we recommend patient assessments for periods longer than 6 months.

Download full-text

Full-text

Available from: Shahla Kakoei, Aug 09, 2015
2 Followers
 · 
266 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: With advances in modern radiotherapy (RT), many patients with head and neck (HN) cancer can be effectively cured. However, xerostomia is a common complication in patients after RT for HN cancer. The purpose of this study was to use the Lyman--Kutcher--Burman (LKB) model to derive parameters for the normal tissue complication probability (NTCP) for xerostomia based on scintigraphy assessments and quality of life (QoL) questionnaires. We performed validation tests of the Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) guidelines against prospectively collected QoL and salivary scintigraphic data. METHODS: Thirty-one patients with HN cancer were enrolled. Salivary excretion factors (SEFs) measured by scintigraphy and QoL data from self-reported questionnaires were used for NTCP modeling to describe the incidence of grade 3+ xerostomia. The NTCP parameters estimated from the QoL and SEF datasets were compared. Model performance was assessed using Pearson's chi-squared test, Nagelkerke's R2, the area under the receiver operating characteristic curve, and the Hosmer--Lemeshow test. The negative predictive value (NPV) was checked for the rate of correctly predicting the lack of incidence. Pearson's chi-squared test was used to test the goodness of fit and association. RESULTS: Using the LKB NTCP model and assuming n=1, the dose for uniform irradiation of the whole or partial volume of the parotid gland that results in 50% probability of a complication (TD50) and the slope of the dose--response curve (m) were determined from the QoL and SEF datasets, respectively. The NTCP-fitted parameters for local disease were TD50=43.6 Gy and m=0.18 with the SEF data, and TD50=44.1 Gy and m=0.11 with the QoL data. The rate of grade 3+ xerostomia for treatment plans meeting the QUANTEC guidelines was specifically predicted, with a NPV of 100%, using either the QoL or SEF dataset. CONCLUSIONS: Our study shows the agreement between the NTCP parameter modeling based on SEF and QoL data, which gave a NPV of 100% with each dataset, and the QUANTEC guidelines, thus validating the cut-off values of 20 and 25 Gy. Based on these results, we believe that the QUANTEC 25/20-Gy spared-gland mean-dose guidelines are clinically useful for avoiding xerostomia in the HN cohort.
    BMC Cancer 12/2012; 12(1):567. DOI:10.1186/1471-2407-12-567 · 3.32 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Older persons are at risk of chronic diseases of the mouth, including dental infections (e.g., caries, periodontitis), tooth loss, benign mucosal lesions, and oral cancer. Another serious oral condition in this population is xerostomia (dry mouth). Xerostomia is a common finding in the elderly people mainly due to their increased use of drugs, possible radiotherapy, malnutrition, pathological situations of the salivary glands and also or simply due to age. Since there is a numerical augmentation of the third-age group worldwide, the problem of xerostomia is a matter of augmenting clinical concern. Certain factors of the saliva, such as pH Ôr/and the flow degree, can be measured directly in one dental appointment with various clinical tests in order to diagnose directly the presence and degree of xerostomia. These tests are carried out through the use of predisposed single-use kits that count the saliva flow and the microbial population of the oral cavity easily, rapidly and economically. Diagnosed xerostomia caused by underlying disease or medication use may be treated with over-the-counter saliva substitutes. The control of xerostomia may lead to control of dental caries since the main intraoral effect of xerostomia is the increased active caries index. The main location of caries in third-age patients is usually the exposed root surfaces (root caries). Effort to assess the microbial population in the mouth of the elderly is the first step to (root) caries prevention. The aim of this literature review is the discussion of the current data concerning saliva’s function, the description of parameters that control the rhythm and the degree of its flow and the tests existed for quantification and examination of its quality. The relevance of saliva with root caries in the elderly population is further discussed. Finally certain protocols are suggested in order to provide prevention or caries treatment and reduce the overall caries risk index of the elderly. Key words:Xerostomia, saliva tests, saliva floe, caries, caries risk assessment
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Alimentary tract (AT) mucositis is a serious and debilitating side effect of cancer therapy, primarily characterised by damage to the mucous membranes throughout the AT, and associated with mouth ulcers and pain, vomiting, diarrhoea, rectal bleeding and abdominal cramps to name a few. Considerable progress has been made in our understanding of the biological basis for mucositis, and the ­understanding of pathobiology continues to evolve. In recent years, the biggest advance has come from the 5-phase model of mucositis development. The main pathobiological features of mucositis include changes to tissue structure, and surface area, microbiome changes and inflammation. With a better understanding of mucositis pathogenesis, the focus of more recent research is shifting to targeted therapy-induced toxicity, toxicity clustering and the investigation of genetic polymorphisms in toxicity prediction. The ultimate goal of mucositis researchers is to identify the most appropriate targets for therapeutic interventions and to be able to predict toxicity risk and personalise interventions to genetically suitable patients. Continuing research efforts are needed to further our understanding of mucositis pathobiology and the pharmacogenomics of toxicity. This book chapter will update our understanding of the recent concepts of mucositis pathogenesis.
    Pathobiology of Cancer Regimen-Related Toxicities, 01/2013: pages 121-146; , ISBN: 978-1-4614-5437-3
Show more